CME Group Inc (CME) concluded trading on Wednesday at a closing price of $254.13, with 6.29 million shares of worth about $1.6 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 17.46% during that period and on April 09, 2025 the price saw a loss of about -0.35%. Currently the company’s common shares owned by public are about 359.60M shares, out of which, 359.25M shares are available for trading.
Stock saw a price change of -3.20% in past 5 days and over the past one month there was a price change of -2.42%. Year-to-date (YTD), CME shares are showing a performance of 9.43% which increased to 22.42% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $186.08 but also hit the highest price of $273.42 during that period. The average intraday trading volume for CME Group Inc shares is 2.39 million. The stock is currently trading -2.82% below its 20-day simple moving average (SMA20), while that difference is up 0.25% for SMA50 and it goes to 13.29% higher than SMA200.
CME Group Inc (NASDAQ: CME) currently have 359.60M outstanding shares and institutions hold larger chunk of about 89.48% of that.
The stock has a current market capitalization of $91.58B and its 3Y-monthly beta is at 0.46. PE ratio of stock for trailing 12 months is 26.27, while it has posted earnings per share of $9.67 in the same period. Its PEG reads 4.21 while making debt-to-equity ratio of 0.14. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CME, volatility over the week remained 4.26% while standing at 2.18% over the month.
Analysts are in expectations that CME Group Inc (CME) stock would likely to be making an EPS of 2.77 in the current quarter, while forecast for next quarter EPS is 2.74 and it is 11.48 for next year. For the current quarter EPS, analysts have given the company a lowest target 2.53 which is 2.86 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 2.5 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 6.23% while it is estimated to increase by 5.09% in next year. EPS is likely to shrink at an annualized rate of 6.24% for next 5-years, compared to annual growth of 10.36% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on April 08, 2025 offering an Overweight rating for the stock and assigned a target price of $301 to it. Coverage by Raymond James stated CME Group Inc (CME) stock as an Outperform in their note to investors on March 10, 2025, suggesting a price target of $287 for the stock. On January 06, 2025, Citigroup Downgrade their recommendations, while on October 08, 2024, Redburn Atlantic Downgrade their ratings for the stock with a price target of $244. Stock get a Sector perform rating from RBC Capital Mkts on September 27, 2024.
